Taking Niacin to Heart


By: Daniel Trecroci

The addition of niacin to existing medical regimens for patients with heart disease and well-controlled LDL levels improves inflammatory markers, according to researchers at Tufts-New England Medical Center in Boston, Massachusetts.

In their study, niacin was added to existing therapy for three months in 54 participants with stable coronary artery disease. Average total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride levels were similar between groups.

“Three months of niacin treatment increased total HDL [good] by 7.5 percent and decreased triglycerides by 15 percent.”

In addition, taking niacin decreased lipoprotein-associated phospholipase A2 and C-reactive protein levels, both inflammation markers that have been implicated in heart disease.

The American Journal of Cardiology, September 15, 2006



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.